Article
Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer.
Pathology oncology research : POR - 1 Oct 2012
Lv Hongying, Li Qicai, Qiu Wengsheng, Xiang Jinyu, Wei Hongjun, Liang Hua, Sui Aihua, Liang Jun
Abstract excerpt
To examine the association between genetic polymorphisms of XRCC1 Arg399Gln(G→A) and response to oxaliplatin-based chemotherapy in advanced colorectal cancer. XRCC1 genotypes of totally 99 patients(37 stage III, 62 stage IV)with advanced colorectal cancer treated with oxaliplatin-based chemotherapy were detected by TaqMan-MGB probe allelic discrimination method. And clinical response of 62 patients in stage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
